Who we are.

Join the fight against pancreatic cancer! The 2015 Pancreatic Cancer Research Walk is Sunday, November 1st at Sloan's Lake Park, Denver, CO.

All the money raised goes directly to pancreatic cancer research thanks to the Lustgarten Foundation!

Friday, November 30, 2012

2012 Denver Walk Video


A powerful video from the 2012 Denver Pancreatic Cancer Walk supporting the Lustgarten Foundation.  

We're making a difference!

Thursday, November 22, 2012

Thanksgiving was Mom's Tradition


Thanksgiving always reminds me of my mom, Hildy.

Hildy Burness passed away from pancreatic cancer early Thanksgiving morning, 2005. She was a beloved teacher for over 20 years at San Francisco Day School, a long-time member of Saint Aidan's Episcopal Church, loving wife of Dave, and great mom to me (Jim) and my brother Pete (and a number of other kids she took under her wing).

Her memorial service at Saint Aidan's was the largest event the building had ever seen, with visitors left standing in the stairwells and out the doors. She was an environmentalist and a recycler long before it was "cool" and was beloved by both her students and her friends for giving it to you straight with a big helping of love. 

Nothing was more important to Mom than her family and her extended family. Thanksgiving was her favorite holiday and our small San Francisco house was always filled to the brim with family and friends (and often some new friends brought along by other friends). She never wanted anyone to alone on that day.  If she heard that you had no place to go, you suddenly did. There was never an option to say no.

Jim Burness, master turkey carver
In fact, Thanksgiving was so important to her, she had a full dinner with all the trimmings the year we didn't even have a kitchen or dining room. The house was undergoing a major remodel and Mom and Dad had been getting by on a hot plate and a microwave oven in the front hallway for months. But this was Thanksgiving, so she secured the use of ovens of the various neighbors who would be away for the holiday, had the construction crew stop what they were doing, and asked them to make a big dining room table out of plywood sheets and sawhorses. As with every other year, the dinner was wonderful, the conversation was lively and the wine never stopped flowing.  It's that Hildy Spirit and Determination we all miss the most.

Table set with loving care

To this day, the tradition continues, beginning with that fateful day.  Each year we all travel to San Francisco -- family and friends -- to celebrate the holiday and of course, Mom.  The family is bigger now and we each play a role in making the feast.  Pete makes the stuffing (or dressing as Mom called it) from her special recipe and I carve the turkey. Our wives take turns between child wrangling and cooking, and my cousin Carol is in charge of the turkey-shaped cranberry cut outs.  It's our celebration of Mom! 


The tradition continues and has long reached beyond this table.  Tables are set up throughout the house.

Jim and his Mom, Hildy.

Monday, November 19, 2012

Precision Targeting. Fewer Side Effects


Both standard X-ray (photon) radiation therapy and proton therapy attack tumors by preventing cancer cells from dividing and growing. The difference between the two therapies is that protons can precisely target the tumor, allowing patients to receive higher, more effective doses, and reducing damage to healthy tissue near the tumor.1 

Click image above to enlarge.
Research shows that proton therapy can cause fewer short- and long-term side effects than standard radiation therapy, reducing the occurrence of secondary tumors and improving quality of life for patients.4-9

BENEFITS AT A GLANCE1-9

  • Causes fewer short- and long-term side effects
  • Proven to be effective in adults and children
  • Targets tumors and cancer cells with precision, reducing the risk of damage to surrounding healthy tissues and organs
  • Reduces the likelihood of secondary tumors caused by treatment
  • Can be used to treat recurrent tumors even in patients who have already received radiation
  • Improves quality of life during and after treatment

Learn more at ProCure.com

Friday, November 16, 2012

What is Pancreatic Cancer?


Treatment depends on the type of pancreatic cancer, stage of the disease, and the patient's general health. Your test results will help your doctor plan a treatment program for you. Your doctor will discuss the risks and benefits of various treatment options with you and your family. Ask your medical team about your concerns so that you will understand and feel comfortable with your treatment decision.
The purpose of cancer treatment is to remove the cancer, shrink the tumor, or stop its growth. Generally, there are three forms of treatment for pancreatic cancer: surgery, chemotherapy, and radiation treatment. These treatments may be used alone or in combination, depending on the stage of the cancer. Surgery removes the cancer, and chemotherapy and radiation treatment work to kill or stop the growth of cancer cells.
This section has more information on:

Staging of Pancreatic Cancer

Staging is the process of describing the extent or spread of the disease at the time of diagnosis. It is essential in choosing the treatment and assessing prognosis. Doctors determine a cancer's stage based on the tumor's size, location, and whether it has spread to other areas of the body.
Every person is unique, and your age, disease, and overall health will affect how your body responds to cancer and treatment. If you have questions about your prognosis, ask your doctor. Your doctor will know about your specific case and can discuss these concerns with you. Based on experience, he or she can advise you about what to expect—not just about life expectancy—but also about ways to improve the quality of your life.
  • Stage 0: Cancer is found only in the lining of the pancreas. Stage 0 is also called carcinoma in situ.
  • Stage I: Cancer is found only in the pancreas. Stage I is divided into stage IA and stage IB, based on the tumor size.
  • Stage IA: Tumor is 2 centimeters or smaller
  • Stage IB: Tumor is larger than 2 centimeters
  • Stage II: Cancer may have spread directly to nearby tissue and organs, or it may have spread to lymph nodes near the pancreas. Stage II is divided into stage IIA and IIB, based on where the cancer has spread.
  • Stage IIA: Cancer has grown outside the confines of the pancreas, but has not spread to nearby lymph nodes.
  • Stage IIB: Cancer has spread to nearby lymph nodes and may have spread to nearby tissue and organs.
  • Stage III: Cancer has spread to the major blood vessels near the pancreatic and may have spread to nearby lymph nodes. Stage III cancers are not generally surgically removable.
  • Stage IV: Cancer has spread to distant organs, such as the liver and lung. It also may have spread to organs and tissues near the pancreas or to lymph nodes.
Many doctors who treat pancreatic cancer prefer a simple staging system with only these three stages:

Potentially resectable

Potentially resectable pancreatic cancer is considered operable, or removable by surgery. In this case, the pancreatic cancer has not spread beyond the region of the pancreas and does not involve important blood vessels or organs around the pancreas. Potentially-resectable tumors account for no more than 20 percent of all cases of pancreatic cancer. The majority of patients have more advanced disease at the time of diagnosis.
Patients with potentially resectable cancer may have preoperative therapy. Preoperative therapy is radiation and/or chemotherapy given before surgery. Postoperative therapy is given after surgery. Preoperative therapy offers several advantages over treatment using immediate surgery. Immediate surgery may prevent patients from receiving postoperative therapy due to poor recovery, whereas preoperative therapy allows all potential surgery patients to receive either chemotherapy and/or radiation treatment. Patients who are candidates for potentially resectable disease are generally well patients and make good candidates for preoperative therapy. Also, preoperative chemotherapy allows early treatment to microscopic metastasis.
Of the patients who have immediate surgery for pancreatic cancer, at least 20 to 25 percent do not recuperate well enough to undergo chemotherapy or radiation treatment, or they require a long recovery period in order to receive such treatment.
The primary goal of preoperative and adjuvant (post-operative) therapy is to reduce the risk of the cancer recurring locally or metastasizing to other organs.
A secondary goal of preoperative therapy is for the tumor to respond to the treatment by shrinking or becoming smaller. A smaller tumor may allow for more complete surgical removal of the tumor and preservation of nearby tissue and organs. Based upon the stage of your cancer, your doctor may advise that you receive treatment before or after surgery.

Locally Advanced

Locally advanced pancreatic cancer has not spread beyond the pancreas but involves vital blood vessels or other organs. It is impossible to surgically remove the tumor at this stage, but surgery may be used to relieve symptoms such as a bile obstruction or jaundice.
Approximately 50 percent of patients are diagnosed with locally advanced pancreatic cancer. Symptoms are usually directly related to the primary tumor. Historically, chemotherapy and radiation have been the standard treatments for patients with locally advanced disease. However, treatment strategies are always evolving and the sequence of particular treatments can vary (chemotherapy first, then chemotherapy plus radiation, or chemotherapy plus radiation, followed by more chemotherapy).

Metastatic

Metastatic—This pancreatic cancer has spread to other organs or areas outside of the pancreas. The cancer can no longer be surgically removed.
Progress in the treatment of metastatic pancreatic cancer has been slow and the prognosis for these patients remains very poor. Symptom relief—including pain management—will be a primary goal of therapy.
Discussions about end-of-life issues and planning are appropriate for patients diagnosed with metastatic pancreatic cancer.

Surgery

Potentially curative surgery is used when diagnostic tests suggest that it is possible to remove all the cancer. Most curative surgery is designed to treat cancers in the head of the pancreas, near the bile duct. Some of these cancers are found early enough because they block the bile duct and cause symptoms.
Surgeries for other parts of the pancreas are mentioned below, but these are performed only when complete removal of the cancer will be possible.
There are three procedures used to remove tumors of the pancreas:
Patients whose cancer cannot be surgically removed may have:

Pancreaticoduodenectomy (Whipple procedure)

The most commonly used operation for attempting to remove a cancer of the exocrine pancreas completely is a pancreaticoduodenectomy, sometimes called the Whipple procedure after the surgeon who first described this operation. This operation removes the head of the pancreas and sometimes the body of the pancreas as well. It also removes part of the stomach, the entire duodenum (first part of the small intestine), a small part of the jejunum (second part of the small intestine), and lymph nodes near the pancreas. The gallbladder and part of the common bile duct are removed and the remaining bile duct is attached to the small intestine so that bile from the liver can continue to enter the small intestine.
This is a major operation that carries a relatively high risk of complications. When this operation is performed in cancer centers by surgeons experienced in the procedure, approximately 2 percent to 5 percent of patients die as a direct result of complications from surgery. When the operation is done in small hospitals or by doctors with less experience, up to 15 percent of patients may die because of surgical complications. Even with a skilled surgeon, about 30 percent to 50 percent of patients will suffer complications from the surgery. These include leaking from the various surgical connections, infections, and bleeding.
For patients to have the most successful outcome, they must be treated by a specialized surgeon who has performed many of these operations at a referral center with extensive experience in pancreatic surgery.
Only about 10 percent of cancers of the pancreas appear to be contained entirely within the pancreas at the time of diagnosis. Attempts to remove the entire cancer by surgery may be successful in some of these patients. But even when there appears to be no spread beyond the pancreas at the time of surgery, cancer cells too few to detect may already have spread to other parts of the body.

Distal Pancreatectomy

This operation removes only the tail of the pancreas or the tail and a portion of the body of the pancreas. The spleen is usually removed as well. This operation is used more often with islet cell tumors found in the tail and body of the pancreas.

Total Pancreatectomy

This operation was once used for tumors in the body or head of the pancreas. It removes the entire pancreas and the spleen. It is now seldom used to treat these types of tumors. When the entire pancreas is removed, patients are left without any islet cells, the cells that produce insulin. This means that patients who have this procedure will develop hard-to-manage diabetes. It is possible to live without a pancreas, but a person without a pancreas becomes totally dependent on injected insulin. Also, there doesn't seem to be any advantage to removing the whole pancreas.

Palliative Procedures

Palliative surgery may be performed if diagnostic tests indicate that the tumor is too widespread to be completely removed. This is done to relieve symptoms or prevent certain complications such as blockage of the bile ducts or the intestine by the cancer. If the cancer has spread too far to be removed completely by surgery, the doctors will focus on palliative treatments intended to relieve or prevent symptoms.
Cancers growing in the head of the pancreas can block the common bile duct as it passes through this part of the pancreas. This may cause pain and digestive problems because the bile can't get into the intestine. The bile chemicals will accumulate in the bloodstream. There are two options for relieving bile duct blockage.
One option is an operation that reroutes the flow of bile from the common bile duct directly into the small intestine and bypasses the pancreas. This operation requires an incision in the abdomen, and it may take several weeks to recover completely. One advantage is that during this procedure, the surgeon may be able to cut the nerves leading to the pancreas. This will reduce or relieve any pain that may be caused by the cancer.
Another part of the palliative operation that can be performed is to reroute the stomach connection to the duodenum (the first part of the small intestine). Often, late in the course of pancreatic cancer, the duodenum becomes blocked by cancer. This will cause pain and vomiting that requires surgery. Bypassing the duodenum when the other palliative procedure is done can often avoid a second operation.
A second option is to place stents (tubes) through an endoscope. In this procedure a doctor views the intestine through a long, lighted tube placed down the patient's throat, through the esophagus, through the stomach, and into the small intestine. The doctor can then insert a small length of tubing (the stent) through the endoscope. This tube helps keep the duodenum open and resists compression from the surrounding cancer. Stents can also be inserted into the bile duct, which is often blocked by the cancer in the pancreas. This is performed with an ERCP described above.
In general, a surgical operation to relieve bile obstruction is considered when the cancer is too widespread to be removed completely by surgery but is still localized enough that the patient has a life expectancy longer than six months. If the cancer is more widespread or the patient is in a weakened condition, stent placement may be recommended.

Treatment for Jaundice

Jaundice is a condition in which a person's skin or whites of the eyes have a yellow discoloration. A person with jaundice may also have dark urine and light stool. Jaundice occurs when bilirubin, a substance produced by the liver, builds up in the blood. Normally, bilirubin travels from the liver down the bile duct and passes through the pancreas just before emptying into the first section of the small intestine, called the duodenum. If a tumor blocks the bile duct, bilirubin backs up into the liver, then spills into the blood. This causes a person to become noticeably yellow, or jaundiced.
Jaundice can usually be relieved by placing a small tube called a biliary stent into the bile duct to hold it open. The stent is placed using endoscopic retrograde cholangiopancreatography (ERCP), a procedure in which a flexible telescope called an endoscope is inserted in the mouth, through the stomach, and into the first part of the small intestine. There, tiny tools are passed through the endoscope to deploy the stent.
Jaundiced patients who have a biliary stent placed in their bile duct are at risk for an infection if the stent becomes blocked. A patient who has a biliary stent needs emergency treatment if he or she develops a fever (100°F or greater) or a return of jaundice.

Treating Pain Caused by Pancreatic Cancer

Pancreatic cancer can cause pain when the tumor presses on nerves or other organs near the pancreas. Many patients can manage this pain with medicines such as opioids. Opioids are a group of medicines that have been used to relieve pain for more than 100 years. When pain medicine is not enough, there are treatments that act on nerves in the abdomen to relieve the pain. The doctor may inject medicine into the area around affected nerves, or cut the nerves to block the feeling of pain. Radiation therapy or chemotherapy can also help relieve pain by shrinking the tumor.

Chemotherapy and Radiation Treatment

Chemotherapy uses drugs to stop the growth of cancer cells either by killing the cells or by stopping them from dividing. These drugs are given intravenously (through a vein) or by mouth. The frequency and duration of the chemotherapy schedule will depend on the particular type of drug that your doctor prescribes. Patients with potentially resectable pancreatic cancer may receive chemotherapy before or after surgery. Chemotherapy is often used to treat pancreas cancer that has metastasized. The kind of chemotherapy you receive and the length of your treatment will be determined by your doctor.
Radiation treatment is a localized therapy that uses high-energy X-rays to destroy cancer cells. Patients receive a prescribed amount of radiation that is directed to the tumor and local lymph nodes. Often, patients receive low doses of chemotherapy along with radiation to increase the effectiveness of the treatment. Patients with resectable pancreas cancer may receive radiation therapy before or after surgery. The type of radiation used depends on the stage of the cancer. A radiation oncologist, a doctor who specializes in radiation therapy, will plan your radiation treatments. The length of your radiation treatment will be determined by your radiation oncologist.
Patients usually receive chemotherapy and radiation on an outpatient basis, which does not require admission to the hospital.
Chemotherapy and radiation therapy are powerful treatments that affect normal cells as well as cancer cells and may cause side effects. Common side effects include fatigue, decreased appetite, occasional nausea, abdominal cramping, and diarrhea. Ask your doctor, nurse, or other member of your healthcare team for information about which side effects you may experience and how to manage them.

Palliative Care

Palliative care is a special type of medical care that focuses on treating symptoms people may have when they are living with a chronic (long-lasting) illness such as cancer.
In palliative care, the goal is to provide the best quality of life possible—even before someone becomes terminally ill. Palliative care can be used when a person is receiving treatment for a disease as well as when there is no useful treatment for the disease.
Palliative care focuses on treating problems from the illness including pain, nausea, loss of appetite, depression, and fatigue. All symptoms are addressed, including physical, emotional, and spiritual problems. Another key feature of palliative care is its focus on not only the patient but the family as well. Chronic illness puts special stress on families, and having support can be very helpful. Talking about and planning for the future can help prepare a person and the person's family to make the best choices for everyone involved.
Last reviewed on 10/13/09
U.S. News's featured content providers were not involved in the selection of advertisers appearing on this website, and the placement of such advertisement in no way implies that these content providers endorse the products and services advertised. Disclaimer and a note about your health.

Sunday, November 11, 2012

Cancer Treatment Centers of America


Pancreatic Cancer: Integrative Treatment Program

Learn More About Pancreatic Cancer Treatment Options at CTCA: Chat with Us | Email Us

Pancreatic Cancer Survivor Roger

Listen to pancreatic cancer survivor Roger recall how he came to CTCA and found a place of hope, where his doctors listened to him and he could be in charge.
Pancreatic cancer is often diagnosed when it’s in an advanced stage. At Cancer Treatment Centers of America (CTCA), our cancer experts target pancreatic cancer with advanced medical therapies and technologies
We also understand that the side effects of the disease can make it difficult to get through pancreatic cancer treatment. Throughout your care, we'll support you with therapies designed to reduce fatigue, prevent malnutrition, alleviate pain and help you stay strong and nourished.

Comprehensive Care Under One Roof

When you travel to us, you’ll find everything you need under one roof. Each of our state-of-the-art cancer hospitals houses the latest pancreatic cancer treatments and technologies. Our staff takes care of every detail of your visit, from gathering your medical records to scheduling your appointments to booking your travel and lodging. 

Once here, our Patient Empowered Care® clinic brings your medical oncologist, clinic nurse, registered dietitian, naturopathic clinician and nurse care manager to you. With this approach, you enjoy greater comfort, convenience and privacy, by meeting with your care team in one room at every appointment.

Pancreatic Cancer Treatment Results

CTCA tracks clinical results for some cancer types and compares them with available national databases. For a comparison of results for advanced-stage pancreatic cancer patients treating at CTCA hospitals with those for patients in the National Cancer Institute’s Surveillance Epidemiology and End Results (SEER) database with similar diagnoses, visit our Pancreatic Cancer Treatment Statistics and Results page.

Your Pancreatic Cancer Treatment Options

To learn more about CTCA cancer hospitals and the pancreatic cancer treatment options available to you, contact us at  888-399-8121 or Chat Now. We’re available 24 hours a day, every day of the week.

Thursday, November 08, 2012

Emotional Support


My husband comes to doctors' appointments with me. He is another set of ears to remember what the doctors say. He also comes up with questions to ask that I've forgotten. - Tarceva patient

Emotional Support for Patients With Advanced Pancreatic Cancer

Understanding feelings and emotions

When you have advanced or metastatic cancer, it can be a very emotional time for you, your family, and friends. Emotions can include fear, anger, sadness, and grief.
Here are some tips to help you and your care partner deal with the emotional challenges you may be facing:
  • Ask for support from those around you.
  • Maintain your daily routine as much as possible.
  • Try to stay active, eat healthy foods, and get enough sleep.
  • Learn how to manage your stress.

Getting support

Many resources are available for you, your family, and friends. Having this support can help all of you to cope with the disease. You may want to consider doing some of these things:
Discuss your fears and concerns. If you are feeling sad or anxious, tell someone about it. Depression and anxiety are very common in people with cancer and may need to be treated. Your healthcare provider (HCP) may be able to help. Or, he or she may refer you to other HCPs in your area who can help.
Join a support group. Talking with other people who have cancer can help you learn how they are managing challenges. It is also an opportunity to support each other.
Keep a journal. Writing about your feelings, emotions, and frustrations can help you cope. It can also help to make a list of the questions you have for your HCP.
Seek support. Talk with your minister, rabbi, or other religious leader. Trained counselors and hospital chaplains can also offer support.
Your family, friends, and others on your support team can help you cope with your disease and treatment. Do not hesitate to ask them to:
  • Go with you to your doctor appointments. They can write down what the doctor tells you during your visits. They can also help you put together a list of questions beforehand to discuss with your doctor during the next appointment.
  • Help you keep track of and report any side effects you may be experiencing to your doctor. Sometimes, they may notice little changes in your health that you may not have noticed yourself.
  • Run errands for you. Use your energy wisely; let others help you with your day-to-day activities.
  • Keep others up-to-date on your health either by phone, group email, or with family meetings.
  • Listen to you when you feel like talking about your disease.
  • Join a support group with you to listen and share experiences with others.
  • Help with insurance issues that may come up. For more information, visit our Coverage and Reimbursement Support section.
  • Join you in a shared pastime. Whether you both play a mean hand of gin rummy or relish the strategy of chess, spend time together enjoying each other's company.
  • Take care of themselves so they can be helpful when you need them.
Emotional support from your family and friends can help make living with advanced pancreatic cancer a little easier. See Care Partner Support for more information on how your care partner can help you.
What does Tarceva treat?

Tarceva is approved for:
Advanced Pancreatic Cancer:
  • Tarceva in combination with gemcitabine is prescribed for patients with advanced-stage pancreatic cancer whose cancer has spread, grown, or cannot be surgically removed and who have not received previous chemotherapy.
Important Safety Information

Possible Side Effects
Everyone reacts differently to Tarceva therapy. So it’s important to know what the side effects are. Although some people may have a life-threatening side effect, most do not.
Your doctor will stop treatment if any serious side effects occur. Be sure to contact your healthcare team if you have symptoms related to these side effects.
Interstitial lung disease (ILD)-like events
Problems occurring in the lungs (including deaths). Tarceva may need to be stopped if new or unexplained serious symptoms of shortness of breath, cough, and fever occur.
Liver and/or kidney problems
Some events have included death. Let your healthcare provider (HCP) know if you have a history of liver or kidney disease.
Gastrointestinal (GI) perforation
A hole that develops in your stomach or intestine. Some events have included death.
Serious skin conditions
Some events have included death.
Bleeding and clotting problems
Heart attack or stroke in patients receiving Tarceva plus gemcitabine for advanced pancreatic cancer.
Eye disorders
Eye irritation and damage to the cornea.
Bleeding events when taking warfarin
Some events have included death. Tell your doctor if you are taking warfarin or non-steroidal anti-inflammatory drugs (NSAIDs).
Pregnancy problems
You should not become pregnant while on treatment with Tarceva. DO NOT breast-feed while receiving treatment with Tarceva.
Additional Safety Information
Call your HCP right away if you have these signs or symptoms:
  • New or worsening skin rash
  • Serious or ongoing diarrhea, nausea, loss of appetite, or vomiting
  • New or worsening shortness of breath or cough
  • Eye irritation
It is important that you tell your HCP about all of the medicines and herbal supplements you are taking. DO NOT start taking any new medicines or herbal supplements before talking with your HCP. DO NOT eat grapefruit or drink grapefruit juice while on treatment with Tarceva, except under the care of your HCP.
Smoking may affect how well Tarceva works for you. If you smoke, you should stop smoking before starting treatment with Tarceva. If you continue to smoke, you should talk to your HCP before taking Tarceva.
The most common side effects are fatigue (feeling tired), rash, nausea, loss of appetite, and diarrhea.
Always let your HCP know if you have any side effects, and ask about the best way to handle them.
Tarceva is not right for everyone. Ask your HCP if once-daily Tarceva is right for you.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visitwww.fda.gov/medwatch, or call  1 (800) FDA-1088.

Wednesday, November 07, 2012

Pancreatic Cancer News

Jim Flick dies of cancer at 82
ESPN
Jim Flick, a golf instructor for more than 50 years whose clients included Tom Lehman and Jack Nicklaus upon joining the Champions Tour, died Monday of pancreatic cancer, his family said. He was 82. Flick taught golf in 23 countries and directed ...
See all stories on this topic »
South Carroll families team up to fight Pancreatic cancer
Carroll County Times
Five years ago Ken Cunzeman and Jim Teesdale didn't know each other, but now the men work together to coordinate the Baltimore affiliate of the Pancreatic Cancer Action Network, advocating for pancreatic cancer research and supporting those living with ...
See all stories on this topic »
Ray Price Diagnosed With Pancreatic Cancer
Taste of Country
Country legend Ray Price has confirmed he's been diagnosed with pancreatic cancer. The 86-year-old Country Music Hall of Famer says he has been undergoing chemotherapy for six months and is encouraged by the results. During an interview with the ...
See all stories on this topic »
Board mulls consolidated finance dept., Sandy aftermath
Wicked Local
November is Pancreatic Cancer Awareness month in Arlington following a proclamation by selectmen Monday night. Thirteen-month pancreatic cancer survivor Judy Pearson recounted her experience being diagnosed with the disease – there were almost no ...
See all stories on this topic »
[OPINION] Together, We Can Beat Pancreatic Cancer
NJ TODAY
Over the past 30 years there has been a revolution in science and medicine, resulting in increased survival rates for many diseases but, unfortunately, pancreatic cancer has not benefited from these advances because historically there hasn't been ...
See all stories on this topic »
Benefit set for Minooka High teacher battling cancer
Joliet Herald News
Within a matter of days he was diagnosed with stage four pancreatic cancer. He has been receiving chemotherapy treatments at the University of Chicago, said co-worker Jen Hanson. “Mike was completely healthy (before this), he didn't even like to take ...
See all stories on this topic »
Candidate in today's Henry County Board election dies; King was local native
CambridgeChronicle.com (blog)
GALVA -- Jim King, a former Democratic two-term Henry County Board member who was seeking re-election to the board today, died Saturday of pancreatic cancer. King, 71, of rural Geneseo, was reared in the Victoria area. Voters in District 1, King's ...
See all stories on this topic »
James 'Seamus' Bickel, 57
Patch.com
In lieu of flowers, memorial contributions may be made to either Pancreatic Cancer Action Network or Jersey Shore Relief American Red Cross. For information, directions or condolence messages to the family, visit www.claytonfuneralhome.com. Related ...
See all stories on this topic »
Officials: Boulder's Clovis Oncology on track to release 'pivotal' results
Daily Camera
Boulder-based Clovis Oncology Inc. remains on track to announce the results for a “pivotal” trial for its metastatic pancreatic cancer treatment by the end of the year, company officials said Monday. Clovis (Nasdaq: CLVS) officials provided the update ...
See all stories on this topic »